Form 8-K - Current report:
SEC Accession No. 0001601830-25-000088
Filing Date
2025-06-18
Accepted
2025-06-18 16:22:09
Documents
12
Period of Report
2025-06-18
Items
Item 5.07: Submission of Matters to a Vote of Security Holders

Document Format Files

Seq Description Document Type Size
1 8-K rxrx-20250618.htm   iXBRL 8-K 29825
  Complete submission text file 0001601830-25-000088.txt   144453

Data Files

Seq Description Document Type Size
2 XBRL TAXONOMY EXTENSION SCHEMA DOCUMENT rxrx-20250618.xsd EX-101.SCH 1788
3 XBRL TAXONOMY EXTENSION LABEL LINKBASE DOCUMENT rxrx-20250618_lab.xml EX-101.LAB 21629
4 XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE DOCUMENT rxrx-20250618_pre.xml EX-101.PRE 12512
14 EXTRACTED XBRL INSTANCE DOCUMENT rxrx-20250618_htm.xml XML 2746
Mailing Address 41S RIO GRANDE STREET SALT LAKE CITY UT 84101
Business Address 41S RIO GRANDE STREET SALT LAKE CITY UT 84101 (385) 269-0203
RECURSION PHARMACEUTICALS, INC. (Filer) CIK: 0001601830 (see all company filings)

EIN.: 464099738 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 8-K | Act: 34 | File No.: 001-40323 | Film No.: 251057240
SIC: 2836 Biological Products, (No Diagnostic Substances)
(CF Office: 03 Life Sciences)